# Trade Mark Journal No.2026/007 13 February 2026

## WO0000001898836 (5)

Office of origin: United States of America

Date of International Registration:16 December 2025
Date of designation in the UK: 16 December 2025

International priority date claimed: 17 June 2025 (United States of America) (99239065)

Class 5
  Pharmaceutical preparations for use in the treatment of nicotine addiction and for the cessation of smoking or vaping; pharmaceutical preparations for use in reducing or eliminating nicotine cravings and withdrawal symptoms and for eliminating the urge to smoke or vape; pharmaceutical preparations for use as an aid to promote a reduction in smoking and vaping and for preventing a smoking or vaping relapse.

Achieve Life Sciences, Inc.

Representative: CHELSEAA ELIZABETH LARSEN Sheppard Mullin Richter & Hampton, LLP, 1540 El Camino Real, Suite 120, Menlo Park CA 94025, UNITED STATES OF AMERICA